54 related articles for article (PubMed ID: 38474101)
21. Properties and Application of Cell-Free DNA as a Clinical Biomarker.
de Miranda FS; Barauna VG; Dos Santos L; Costa G; Vassallo PF; Campos LCG
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502023
[TBL] [Abstract][Full Text] [Related]
22. The Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer.
Toledano-Fonseca M; Cano MT; Inga E; Gómez-España A; Guil-Luna S; García-Ortiz MV; Mena-Osuna R; De la Haba-Rodriguez JR; Rodríguez-Ariza A; Aranda E
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33802006
[TBL] [Abstract][Full Text] [Related]
23. Cell-free DNA concentration and fragment size as a biomarker for prostate cancer.
Chen E; Cario CL; Leong L; Lopez K; Márquez CP; Chu C; Li PS; Oropeza E; Tenggara I; Cowan J; Simko JP; Chan JM; Friedlander T; Wyatt AW; Aggarwal R; Paris PL; Carroll PR; Feng F; Witte JS
Sci Rep; 2021 Mar; 11(1):5040. PubMed ID: 33658587
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil to lymphocyte ratio predicts prognosis in unresectable pancreatic cancer.
Iwai N; Okuda T; Sakagami J; Harada T; Ohara T; Taniguchi M; Sakai H; Oka K; Hara T; Tsuji T; Komaki T; Kagawa K; Yasuda H; Naito Y; Itoh Y
Sci Rep; 2020 Oct; 10(1):18758. PubMed ID: 33127996
[TBL] [Abstract][Full Text] [Related]
25. Role of circulating free DNA in evaluating clinical tumor burden and predicting survival in Chinese metastatic colorectal cancer patients.
Xu X; Yu Y; Shen M; Liu M; Wu S; Liang L; Huang F; Zhang C; Guo W; Liu T
BMC Cancer; 2020 Oct; 20(1):1006. PubMed ID: 33066758
[TBL] [Abstract][Full Text] [Related]
26. Circulating cell-free DNA level predicts all-cause mortality independent of other predictors in the Health 2000 survey.
Kananen L; Hurme M; Jylhä M; Härkänen T; Koskinen S; Stenholm S; Kähönen M; Lehtimäki T; Ukkola O; Jylhävä J
Sci Rep; 2020 Aug; 10(1):13809. PubMed ID: 32796872
[TBL] [Abstract][Full Text] [Related]
27. Circulating Cell-Free DNA-Based Liquid Biopsy Markers for the Non-Invasive Prognosis and Monitoring of Metastatic Pancreatic Cancer.
Toledano-Fonseca M; Cano MT; Inga E; Rodríguez-Alonso R; Gómez-España MA; Guil-Luna S; Mena-Osuna R; de la Haba-Rodríguez JR; Rodríguez-Ariza A; Aranda E
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32630266
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of blood testing combined with PET-CT to screen for cancer and guide intervention.
Lennon AM; Buchanan AH; Kinde I; Warren A; Honushefsky A; Cohain AT; Ledbetter DH; Sanfilippo F; Sheridan K; Rosica D; Adonizio CS; Hwang HJ; Lahouel K; Cohen JD; Douville C; Patel AA; Hagmann LN; Rolston DD; Malani N; Zhou S; Bettegowda C; Diehl DL; Urban B; Still CD; Kann L; Woods JI; Salvati ZM; Vadakara J; Leeming R; Bhattacharya P; Walter C; Parker A; Lengauer C; Klein A; Tomasetti C; Fishman EK; Hruban RH; Kinzler KW; Vogelstein B; Papadopoulos N
Science; 2020 Jul; 369(6499):. PubMed ID: 32345712
[TBL] [Abstract][Full Text] [Related]
29. Early detection of pancreatic cancer.
Pereira SP; Oldfield L; Ney A; Hart PA; Keane MG; Pandol SJ; Li D; Greenhalf W; Jeon CY; Koay EJ; Almario CV; Halloran C; Lennon AM; Costello E
Lancet Gastroenterol Hepatol; 2020 Jul; 5(7):698-710. PubMed ID: 32135127
[TBL] [Abstract][Full Text] [Related]
30. Current and emerging therapies for patients with advanced pancreatic ductal adenocarcinoma: a bright future.
Christenson ES; Jaffee E; Azad NS
Lancet Oncol; 2020 Mar; 21(3):e135-e145. PubMed ID: 32135117
[TBL] [Abstract][Full Text] [Related]
31. The clinical value of total plasma cell-free DNA in hepatitis B virus-related hepatocellular carcinoma.
Wang D; Hu X; Long G; Xiao L; Wang ZM; Zhou LD
Ann Transl Med; 2019 Nov; 7(22):650. PubMed ID: 31930051
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 22 Signaling Regulates Acinar Cell Plasticity to Promote Pancreatic Tumor Development in Mice.
Perusina Lanfranca M; Zhang Y; Girgis A; Kasselman S; Lazarus J; Kryczek I; Delrosario L; Rhim A; Koneva L; Sartor M; Sun L; Halbrook C; Nathan H; Shi J; Crawford HC; Pasca di Magliano M; Zou W; Frankel TL
Gastroenterology; 2020 Apr; 158(5):1417-1432.e11. PubMed ID: 31843590
[TBL] [Abstract][Full Text] [Related]
33. Stromal Microenvironment Shapes the Intratumoral Architecture of Pancreatic Cancer.
Ligorio M; Sil S; Malagon-Lopez J; Nieman LT; Misale S; Di Pilato M; Ebright RY; Karabacak MN; Kulkarni AS; Liu A; Vincent Jordan N; Franses JW; Philipp J; Kreuzer J; Desai N; Arora KS; Rajurkar M; Horwitz E; Neyaz A; Tai E; Magnus NKC; Vo KD; Yashaswini CN; Marangoni F; Boukhali M; Fatherree JP; Damon LJ; Xega K; Desai R; Choz M; Bersani F; Langenbucher A; Thapar V; Morris R; Wellner UF; Schilling O; Lawrence MS; Liss AS; Rivera MN; Deshpande V; Benes CH; Maheswaran S; Haber DA; Fernandez-Del-Castillo C; Ferrone CR; Haas W; Aryee MJ; Ting DT
Cell; 2019 Jun; 178(1):160-175.e27. PubMed ID: 31155233
[TBL] [Abstract][Full Text] [Related]
34. Inflammation and development of pancreatic ductal adenocarcinoma.
Shi J; Xue J
Chin Clin Oncol; 2019 Apr; 8(2):19. PubMed ID: 31070039
[TBL] [Abstract][Full Text] [Related]
35. Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer.
Lapin M; Oltedal S; Tjensvoll K; Buhl T; Smaaland R; Garresori H; Javle M; Glenjen NI; Abelseth BK; Gilje B; Nordgård O
J Transl Med; 2018 Nov; 16(1):300. PubMed ID: 30400802
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis.
Chen L; Zhang Y; Cheng Y; Zhang D; Zhu S; Ma X
Gene; 2018 Dec; 679():328-334. PubMed ID: 30227250
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Roles of Inflammatory Markers in Pancreatic Cancer: Comparison between the Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio.
Oh D; Pyo JS; Son BK
Gastroenterol Res Pract; 2018; 2018():9745601. PubMed ID: 29977290
[TBL] [Abstract][Full Text] [Related]
38. Circulating cell-free DNA content as blood based biomarker in endometrial cancer.
Cicchillitti L; Corrado G; De Angeli M; Mancini E; Baiocco E; Patrizi L; Zampa A; Merola R; Martayan A; Conti L; Piaggio G; Vizza E
Oncotarget; 2017 Dec; 8(70):115230-115243. PubMed ID: 29383155
[TBL] [Abstract][Full Text] [Related]
39. A meta-analysis of the utility of the neutrophil-to-lymphocyte ratio in predicting survival after pancreatic cancer resection.
Mowbray NG; Griffith D; Hammoda M; Shingler G; Kambal A; Al-Sarireh B
HPB (Oxford); 2018 May; 20(5):379-384. PubMed ID: 29336893
[TBL] [Abstract][Full Text] [Related]
40. Performance status and neutrophil-lymphocyte ratio are important prognostic factors in elderly patients with unresectable pancreatic cancer.
Kadokura M; Ishida Y; Tatsumi A; Takahashi E; Shindo H; Amemiya F; Takano S; Fukasawa M; Sato T; Enomoto N
J Gastrointest Oncol; 2016 Dec; 7(6):982-988. PubMed ID: 28078122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
